Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.217,19
0,32%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Genelux Corporation (GNLX) Genelux Corporation (GNLX) Notizie

GNLX

Genelux (GNLX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GNLX
DataOraFonteTitoloSimboloCompagnia
14/06/202422:20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:GNLXGenelux Corporation
14/06/202422:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GNLXGenelux Corporation
14/06/202422:10Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GNLXGenelux Corporation
08/06/202403:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
05/06/202403:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
24/05/202423:19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GNLXGenelux Corporation
24/05/202414:00GlobeNewswire Inc.Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying WarrantsNASDAQ:GNLXGenelux Corporation
23/05/202422:01GlobeNewswire Inc.Genelux Corporation Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:GNLXGenelux Corporation
09/05/202422:25GlobeNewswire Inc.Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
09/05/202422:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GNLXGenelux Corporation
01/04/202413:00GlobeNewswire Inc.Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:GNLXGenelux Corporation
14/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GNLXGenelux Corporation
02/02/202422:36Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GNLXGenelux Corporation
02/02/202422:06Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GNLXGenelux Corporation
15/12/202322:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
27/11/202313:00GlobeNewswire Inc.Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian CancerNASDAQ:GNLXGenelux Corporation
14/11/202323:50GlobeNewswire Inc.Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
19/09/202323:37Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:GNLXGenelux Corporation
14/09/202313:00GlobeNewswire Inc.Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GNLXGenelux Corporation
14/09/202302:13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
07/09/202322:01GlobeNewswire Inc.Genelux Corporation to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:GNLXGenelux Corporation
28/08/202313:00GlobeNewswire Inc.Genelux Corporation Announces New Chief Financial OfficerNASDAQ:GNLXGenelux Corporation
14/08/202313:00GlobeNewswire Inc.Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
02/08/202322:00GlobeNewswire Inc.Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2023NASDAQ:GNLXGenelux Corporation
20/07/202322:45GlobeNewswire Inc.Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New HiresNASDAQ:GNLXGenelux Corporation
29/06/202313:00GlobeNewswire Inc.Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics™, LLCNASDAQ:GNLXGenelux Corporation
29/06/202312:02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:GNLXGenelux Corporation
22/06/202313:00GlobeNewswire Inc.Genelux Corporation Set to Join the Russell 3000® and Russell 2000® Indexes Effective June 26, 2023NASDAQ:GNLXGenelux Corporation
12/06/202313:00GlobeNewswire Inc.Genelux Corporation Announces $18 Million Private PlacementNASDAQ:GNLXGenelux Corporation
12/06/202312:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNLXGenelux Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GNLX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
NEXI
Nexi S.p.A
BIT
TIT
Telecom Italia
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network